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Nebulin and dystrophin are two high-molecular-mass skeletal muscle proteins that have both been associated with the 
defective gene in Duchenne muscular dystrophy, although the function of neither protein is known. Other high-molecu- 
lar-mass, calmodulin-binding proteins have recently been implicated in regulating calcium release from skeletal muscle. 
Western blots of human skeletal muscle biopsy samples were probed with biotinylated calmodulin; nebulin was identified 
as a prominent high-molecular-mass calmodulin-binding protein but dystrophin did not bind detectable amounts of bio- 
tinylated calmodulin. Dystrophin was absent in a Duchenne muscle biopsy. 
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1. INTRODUCTION 
The structure and function of high-molecular- 
mass proteins in junctional sarcoplasmic reticulum 
and the cytoskeletal matrix have recently received 
much attention. Skeletal muscle contraction is 
regulated by release of calcium from specialized 
regions in the junctional reticulum, known as junc- 
tional triads or feet, which in the electron 
microscope are seen as a four-leafed clover struc- 
ture, spanning the membrane between the 
transverse tubular system and the sarcoplasmic 
reticulum. The calcium-release channel protein is 
one of a number of these high-molecular-mass pro- 
teins which both bind calmodulin and are 
phosphorylated by a variety of endogenous protein 
kinases [ 1,2]. Dystrophin, the protein associated 
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with the defective gene product in Duchenne 
muscular dystrophy 131, has recently been shown 
to fractionate with junctional feet membrane 
preparations, although it is distinct (both im- 
munologically and on the basis of size) from the 
calcium-release channel protein [4]. The N- 
terminal amino acid sequence of dystrophin shows 
considerable similarities to the highly conserved 
actin-filament-binding domain of chicken 
cytoskeletal cu-actinin [5]. This has led to the sug- 
gestion that dystrophin might form an anchor for 
the triads to the myofibrillar cytoskeleton, through 
the binding of actin filaments [4]. Nebulin is 
another high-molecular-mass protein of the 
myofibrillar matrix that has been linked with the 
defective gene in Duchenne muscular dystrophy 
[6]. Nebulin coexists with thick and thin filaments 
and, speculatively, provides a scaffold for these 
filamentous structures [7]. Calmodulin is involved 
in skeletal muscle contraction at many levels, e.g. 
the regulation of calcium release from the sar- 
coplasmic reticulum and the interaction with 
cytoskeletal calcium regulatory proteins [8,9]. Lit- 
tle is known about the functional roles of either 
nebulin or dystrophin; as one approach to this pro- 
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blem, we have examined whether either of these 
two proteins are involved in calcium regulation, by 
examining their ability to interact with calmodulin. 
2. EXPERIMENTAL 
2.1. Materials 
Samples of fresh human muscle were obtained by needle 
biopsy of the vastus lateralis, from patients attending the mus- 
cle clinic. Patient diagnosis was assessed by clinical, 
histochemical, electron microscopical, serum enzyme and elec- 
tromyographical criteria [lo]. Control muscle samples were 
from biopsies which showed no clinical abnormalities. Sheep 
antibodies to the 60 and 90 kDa dystrophin fusion proteins 
were the generous gift of Drs E. Hoffman and L. Kunkel 
(Boston, USA). Goat antibody to nebulin was a generous gift 
from Drs J. Whardale and J. Trinnick (Bristol, England). 
Streptavidin-biotinylated peroxidase was obtained from 
DAKO, streptavidin-biotinylated alkaline phosphatase from 
Vector Labs and biotinylated calmodulin from Penninsular 
Labs. Biotinylated IgG (donkey, anti-sheep/goat) was obtained 
from Amersham and biotinylated IgG (rabbit, anti-goat) from 
Tissue Culture Services. Human serum was obtained from the 
North London Blood Centre. Nitrocellulose blotting matrices 
were purchased from Schleicher and Schuell. Electrophoresis 
reagents were obtained from BDH; protease inhibitors and 
diaminobenzidine were obtained from Sigma. 
2.2. Electrophoresis 
Human muscle biopsy samples (approx. 2 mg) were 
homogenised in 1% SDS (w/v) containing 1 mg/ml PMSF, 
1 mM iodoacetamide, 1 mM benzemethonium chloride, 5 mM 
EGTA, 0.25 mg/ml pepstatin A. After centrifugation at 12000 
x g for 1 min, the supernatant was assayed for protein and a 
volume corresponding to 50 pg protein was electrophoresed on 
a 4-20’70 linear gradient SDS polyacrylamide gel [ 111. Gels were 
then fixed with 20% trichloroacetic acid and stained with 0.5% 
Coomassie brilliant blue R250 in 45% methanol/lO% acetic 
acid. Alternatively, after electrophoresis, gels were gently 
agitated in blotting buffer (20 mM Tris base, 150 mM glycine) 
for 30 min before being electrophoretically transferred onto 
nitrocellulose paper (500 mA, 15 h, 15”C), conditions which 
have been optimised in our laboratory for the transfer of high- 
molecular-mass proteins [12]. Proteins remaining on the 
polyacrylamide gel were stained with silver [13]. Blot transfers 
were probed as indicated below. 
2.3. Calmodulin binding 
Blots were preincubated with TCaP buffer to block non- 
specific binding [14] before incubation for 1 h with biotinylated 
calmodulin (1 &ml) containing 1 pM Ca’+. Blots were then in- 
cubated for 1 h with a preformed streptavidin-biotinylated 
peroxidase complex (each reagent diluted 1 :5000 in 1 pM 
Ca2+/PBS and mixed for 30 min) before being finally exposed 
to freshly prepared diaminobenzidine (O.O25%)/hydrogen 
peroxide (0.005Oro) for less than 1 min. Blots were washed 
(3-times) between each step, with TCaP buffer. Calcium- 
independent calmodulin binding was determined in the absence 
of added Ca2+ and in the presence of 5 mM EGTA. 
268 
2.4. Dystrophin detection 
Non-specific binding was blocked with TP buffer; the buffer 
was also used to wash the blots (3 times) between each process- 
ing stage. Blots were initially probed with antibody to a 90 kDa 
fusion protein derived from a fragment of a dystrophin cDNA 
clone isolated from mouse cardiac muscle [3]. Blots were then 
labelled with biotinylated donkey anti-sheep/goat IgG (1 : 400 in 
human serum/TP buffer, 1 : 1) for 60 min before being finally 
probed with a streptavidin-peroxidase complex as described 
above. As an alternative to peroxidase staining, the blot was 
finally probed with a streptavidin-alkaline phosphatase com- 
plex (prepared as for the peroxidase complex, using 1: 250 dilu- 
tions of each reagent), followed by visualisation with Fast Red 
solution [lo mg naphthol phosphate in 1 ml dimethylfor- 
mamide/50 mg Fast Red in 49 ml of 0.1 M Tris buffer (pH 8.2) 
and filtered before use]. 
2.5. Nebulin detection 
TP buffer was used, both to block non-specific binding sites 
and to wash the blots, as described above. Blots were initially 
probed with anti-nebulin antibody (1: 1000 in TP buffer) for 
1 h. The blots were then incubated with biotinylated rabbit anti- 
goat IgG (1:200 in human serum/TP buffer, 1: 1) for 1 h and 
processed with the streptavidin-peroxidase complex as de- 
scribed above. 
3. RESULTS 
We found that nebulin was very susceptible to 
degradation and could only be reproducibly 
observed on SDS gels with a size of approx. 
500 kDa (fig.1) if a cocktail of protease inhibitors 
was included in the muscle homogenisation 
medium, in agreement with previous results [7]. 
The natural abundance of dystrophin was too low 
to be detected in whole muscle by direct protein 
staining. 
Biotinylated calmodulin has recently been 
shown to be a convenient and sensitive probe for 
detecting calmodulin-binding proteins of mem- 
brane preparations after gel electrophoresis [ 151. 
With this particular probe, nebulin appears to be 
a major calmodulin-binding protein in human 
skeletal muscle. Fig.2 shows the results from a nor- 
mal muscle biopsy sample run out on an SDS gel 
and probed with (A) anti-nebulin antibody, (B) 
biotinylated calmodulin and (C) anti-dystrophin 
antibody (to 90 kDa fusion protein). Evidence of 
the susceptibility of nebulin to degradation is also 
shown in the number of immunologically reactive 
lower molecular mass bands seen in fig.2A. The 
presence of dystrophin in the biopsied muscle can 
readily be seen on the blot probed with the 
dystrophin antibody, as an immunoreactive 
doublet (fig.ZC). We have no indication as to the 
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Fig.1. SDS-PAGE of identical samples of a normal human 
muscle biopsy, solubilised with a cocktail of protease inhibitors 
and stained with Coomassie blue; N, nebulin. Molecular mass 
markers indicated (in kDa). 
origins of this doublet at present but it is a regular 
feature from blots of all muscle samples containing 
dystrophin that we have examined. In comparison 
to nebulin, dystrophin appears to be an extremely 
stable protein and can be detected with the an- 
tibody probe, irrespective of whether protease in- 
hibitors are included during muscle homogenisa- 
tion (not shown). Similar results were obtained 
with antibody to the 60 kDa dystrophin fusion 
protein (not shown). There is no evidence from 
fig.2B to suggest that dystrophin is a major 
calmodulin-binding protein although we cannot 
rule out the possibility that binding occurs below 
the levels of our detection. The efficiency of 
transfer of these high-molecular-mass proteins to 
the blotting membrane was verified by silver stain- 
ing the post-blotted polyacrylamide gel (not 
shown). Control experiments, omitting either anti- 
dystrophin or anti-nebulin antibodies, showed no 
staining with second antibody. 
Fig.2. Calmodulin-binding profiles of nebulin and dystrophin. 
SDS-PAGE of identical, normal human muscle biopsy samples, 
electrophoretically transferred to nitrocellulose and probed 
with (A) anti-nebulin antibody, (B) biotinylated calmoduhn and 
(C) anti-dystrophin antibody. N, nebulin; D, dystrophin. 
The binding of calmodulin to nebulin (as well as 
to all the other calmodulin-binding proteins 
detected in fig.2B) was calcium-dependent. Fig.3 
shows SDS gel profiles of five different muscle 
biopsy samples (four normal, one Duchenne) 
probed with biotinylated calmodulin/l ,uM Ca2+ 
(A), biotinylated calmodulin/5 mM EGTA (B) 
and anti-dystrophin antibody (against 90 kDa 
fusion protein) (C). Similar (but more intensely 
stained) binding patterns were seen in the presence 
of 1 mM Ca (not shown). None of the proteins 
identified in fig.3A were stained in the presence of 
the calcium-chelating agent, EGTA (fig.3B). Apart 
from nebulin, many other calmodulin-binding pro- 
teins were labelled (fig.3A) and those tentatively 
identified include myosin heavy chain (200 kDa), 
calmodulin-dependent sarcolemmal Ca2+-ATPase 
(approx. 150 kDa), myosin light chain kinase 
(95 kDa), calsequestrin (63 kDa), and troponin I 
(23 kDa). The Duchenne muscle sample run out on 
lane e clearly contains nebulin (as shown by 
calmodulin binding, fig.3A), but totally lacks 
dystrophin (fig.3C). 
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Fig.3. Calcium dependence of calmodulin binding. SDS-PAGE 
of four different, normal human muscle biopsy samples (lanes 
a-d) and a Duchenne dystrophy muscle biopsy sample (lane e), 
electrophoretically transferred to nitrocellulose and probed 
with (A) biotinylated calmodulin, (B) biotinylated calmodulin 
in the presence of 1 mM EGTA and (C) anti-dystrophin 
antibody. 1, myosin heavy chain (200 kDa); 2, calmodulin- 
dependent sarcolemmal Ca’+-ATPase (approx. 150 kDa); 3, 
myosin light chain kinase (95 kDa); 4, calsequestrin (63 kDa); 
5, troponin I (23 kDa). 
4. DISCUSSION 
Nebulin is one of the major myofibrillar pro- 
teins of skeletal muscle [7]. Until recently it was 
believed to play a purely structural role in stabilis- 
ing the myofilament lattice. However direct 
evidence from radiation inactivation experiments 
suggests that both nebulin and titin (another high- 
molecular-mass myofibrillar protein) are asso- 
ciated with the maintenance of resting tension 
within the muscle fibre [16]. Titin and nebulin can 
be phosphorylated, although only 15% of total 
titin phosphates exchanged with cytosolic ATP 
within 3 days; it has been suggested that the ma- 
jority of phosphorylation sites are therefore more 
likely to have a structural, rather than a regulatory 
role [17]. However, the fact that nebulin is much 
more intensively labelled than titin [17], coupled 
with our observations that nebulin is a major 
calmodulin-binding protein, indicate that some of 
these phosphorylation sites may indeed play a 
regulatory role in the assembly and turnover of the 
myofibril, at least as far as nebulin is concerned. 
Until dystrophin was identified, nebulin had 
been postulated to be the defective gene product of 
Duchenne dystrophy [6]. The identification of 
nebulin in the Duchenne muscle biopsy studied 
here (illustrative of many other Duchenne biopsies 
examined) provides further support against this 
argument. Nebulin expression has recently been 
shown to be normal in other Duchenne muscle 
biopsies, using a combination of immunocyto- 
chemical and immunoblotting techniques [ 181. 
Dystrophin appears to be a rather stable protein, 
unlike many other high-molecular-mass muscle 
proteins such as nebulin, titin and junctional feet 
proteins, which are extremely sensitive to degrada- 
tion by proteases. The origins of the immunoreac- 
tive doublet invariably observed when muscle 
samples are probed with anti-dystrophin antibody 
are intriguing; whether this represents different 
gene products or a form of post-translational 
modification is unclear at present. 
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